Literature DB >> 24356738

[Uric acid and purine plasma levels as plausible markers for placental dysfunction in pre-eclampsia].

Carlos Escudero1, Patricio Bertoglia2, Felipe Muñoz2, James M Roberts3.   

Abstract

Uric acid is the final metabolite of purine break down, such as ATP, ADP, AMP, adenosine, inosine and hypoxanthine. The metabolite has been used broadly as a renal failure marker, as well as a risk factor for maternal and neonatal morbidity during pre-eclamptic pregnancies. High purine levels are observed in pre-eclamptic pregnancies, but the sources of these purines are unknown. However, there is evidence that pre-eclampsia (mainly severe pre-eclampsia) is associated with an increased release of cellular fragments (or microparticles) from the placenta to the maternal circulation. These in fact could be the substrate for purine metabolism. Considering this background, we propose that purines and uric acid are part of the same physiopathological phenomenon in pre-eclampsia (i.e., placental dysfunction) and could become biomarkers for placental dysfunction and postnatal adverse events.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24356738     DOI: 10.4067/S0034-98872013000700009

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  2 in total

Review 1.  Physiological mechanisms of vascular response induced by shear stress and effect of exercise in systemic and placental circulation.

Authors:  Iván Rodríguez; Marcelo González
Journal:  Front Pharmacol       Date:  2014-09-16       Impact factor: 5.810

2.  Serum urea acid and urea nitrogen levels are risk factors for maternal and fetal outcomes of pregnancy: a retrospective cohort study.

Authors:  Lanlan Wu; Yao Liu; Zengyou Liu; Hengying Chen; Siwen Shen; Yuanhuan Wei; Ruifang Sun; Guifang Deng
Journal:  Reprod Health       Date:  2022-09-15       Impact factor: 3.355

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.